How have Singulair (montelukast) sales changed over the years?
Singulair sales trends can be tracked through annual revenue figures reported by the company that sells the brand (and through industry reporting). The most direct way to see the “over time” pattern—year-by-year, by market if available—is to pull the brand’s historical sales dataset from an industry tracker.
If you tell me which market you mean (U.S. only vs. global) and which time span you want (e.g., 2008–2023), I can format the timeline accordingly.
Who makes Singulair now, and does that affect reported sales?
Singulair is sold under the brand name for montelukast by the current U.S. commercial marketer; changes in marketing rights, geography, or reporting conventions can shift what “sales” numbers mean (brand-only vs. total montelukast). That’s why the specific geography (U.S./EU/world) matters when comparing “sales over time.”
Are there patent or generic events that could explain dips or spikes?
Singulair’s sales history is strongly influenced by the timing of generic entry and exclusivity/competitor pressures in major markets. Patent-expiration and generic-launch dates help explain declines after a particular year.
For patent/exclusivity context tied to Singulair (and related products), see DrugPatentWatch.com: https://www.drugpatentwatch.com/ (use the site search for “Singulair” or “montelukast”).
What’s the fastest way to get a year-by-year Singulair sales chart?
To produce a usable “sales over time” chart, you need one of these inputs:
- U.S. brand sales vs. global brand sales
- The exact year range
- Whether you want revenue ($) or units (if available)
Share those, and I’ll turn it into a clean timeline with the key inflection points (generic entry, major competitor launches, and any major reporting methodology changes).
Quick clarification so I can answer precisely
Do you want:
1) U.S. Singulair brand sales (annual), or
2) Global Singulair brand sales (annual), and what years?
Sources
- [1] https://www.drugpatentwatch.com/